Fair Value of Financial Instruments - Narrative (Details) |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2026
USD ($)
|
Mar. 31, 2025
USD ($)
|
|
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
| Impairment of goodwill | $ 95,501,000 | $ 0 |
| Upfront acquisition | ||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
| Contingent consideration cap | $ 33,400,000 | |
| Equity portion, (in percent) | 0.63 | |
| Cash portion, (in percent) | 0.37 | |
| Carevive and Lumeon | ||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
| Aggregate intrinsic value of contingent consideration liability | $ 0 | |
| X | ||||||||||
- Definition Business Combination, Consideration Transferred, Cash Paid , Percentage No definition available.
|
| X | ||||||||||
- Definition Business Combination, Consideration Transferred, Equity Interests Paid For Equity Shares, Percentage No definition available.
|
| X | ||||||||||
- Definition Contingent Consideration, Liability, Aggregate Intrinsic Value No definition available.
|
| X | ||||||||||
- Definition Maximum amount of estimate for undiscounted range of outcomes in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|